Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enhanced Athlete is a performance-focused supplement company that gained significant notoriety for its involvement in the distribution of Selective Androgen Receptor Modulators (SARMs) and other research chemicals. Founded by Charles Anthony Hughes (known as Tony Huge) and Scott Cavell, the company targeted the bodybuilding and fitness markets with products designed for rapid muscle growth and fat loss. The organization faced extensive legal scrutiny, resulting in a 2019 Department of Justice case regarding the misbranding of drugs and the sale of unapproved substances. While the original business model centered on experimental compounds, the brand has since pivoted toward more conventional dietary supplements under the Enhanced label. The company remains a controversial figure in the sports nutrition industry due to its history of promoting substances not approved for human consumption.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enhanced Athlete.